BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 37463915)

  • 1. Adipose tissue and skeletal muscle wasting precede clinical diagnosis of pancreatic cancer.
    Babic A; Rosenthal MH; Sundaresan TK; Khalaf N; Lee V; Brais LK; Loftus M; Caplan L; Denning S; Gurung A; Harrod J; Schawkat K; Yuan C; Wang QL; Lee AA; Biller LH; Yurgelun MB; Ng K; Nowak JA; Aguirre AJ; Bhatia SN; Vander Heiden MG; Van Den Eeden SK; Caan BJ; Wolpin BM
    Nat Commun; 2023 Jul; 14(1):4317. PubMed ID: 37463915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MEF2c-Dependent Downregulation of Myocilin Mediates Cancer-Induced Muscle Wasting and Associates with Cachexia in Patients with Cancer.
    Judge SM; Deyhle MR; Neyroud D; Nosacka RL; D'Lugos AC; Cameron ME; Vohra RS; Smuder AJ; Roberts BM; Callaway CS; Underwood PW; Chrzanowski SM; Batra A; Murphy ME; Heaven JD; Walter GA; Trevino JG; Judge AR
    Cancer Res; 2020 May; 80(9):1861-1874. PubMed ID: 32132110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. JNK signaling contributes to skeletal muscle wasting and protein turnover in pancreatic cancer cachexia.
    Mulder SE; Dasgupta A; King RJ; Abrego J; Attri KS; Murthy D; Shukla SK; Singh PK
    Cancer Lett; 2020 Oct; 491():70-77. PubMed ID: 32735910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in cancer cachexia: Intersection between affected organs, mediators, and pharmacological interventions.
    Siddiqui JA; Pothuraju R; Jain M; Batra SK; Nasser MW
    Biochim Biophys Acta Rev Cancer; 2020 Apr; 1873(2):188359. PubMed ID: 32222610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic cancer induces muscle wasting by promoting the release of pancreatic adenocarcinoma upregulated factor.
    Yoo W; Choi H; Son YH; Lee J; Jo S; Jung D; Kim YJ; Koh SS; Yang YR; Kwon ES; Lee KP; Noh KH; Kim KW; Ko Y; Jun E; Kim SC; Kim S
    Exp Mol Med; 2021 Mar; 53(3):432-445. PubMed ID: 33731895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered exocrine function can drive adipose wasting in early pancreatic cancer.
    Danai LV; Babic A; Rosenthal MH; Dennstedt EA; Muir A; Lien EC; Mayers JR; Tai K; Lau AN; Jones-Sali P; Prado CM; Petersen GM; Takahashi N; Sugimoto M; Yeh JJ; Lopez N; Bardeesy N; Fernandez-Del Castillo C; Liss AS; Koong AC; Bui J; Yuan C; Welch MW; Brais LK; Kulke MH; Dennis C; Clish CB; Wolpin BM; Vander Heiden MG
    Nature; 2018 Jun; 558(7711):600-604. PubMed ID: 29925948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Body composition in patients with non-small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis.
    Baracos VE; Reiman T; Mourtzakis M; Gioulbasanis I; Antoun S
    Am J Clin Nutr; 2010 Apr; 91(4):1133S-1137S. PubMed ID: 20164322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central tenet of cancer cachexia therapy: do patients with advanced cancer have exploitable anabolic potential?
    Prado CM; Sawyer MB; Ghosh S; Lieffers JR; Esfandiari N; Antoun S; Baracos VE
    Am J Clin Nutr; 2013 Oct; 98(4):1012-9. PubMed ID: 23966429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postdiagnosis Loss of Skeletal Muscle, but Not Adipose Tissue, Is Associated with Shorter Survival of Patients with Advanced Pancreatic Cancer.
    Babic A; Rosenthal MH; Bamlet WR; Takahashi N; Sugimoto M; Danai LV; Morales-Oyarvide V; Khalaf N; Dunne RF; Brais LK; Welch MW; Zellers CL; Dennis C; Rifai N; Prado CM; Caan B; Sundaresan TK; Meyerhardt JA; Kulke MH; Clish CB; Ng K; Vander Heiden MG; Petersen GM; Wolpin BM
    Cancer Epidemiol Biomarkers Prev; 2019 Dec; 28(12):2062-2069. PubMed ID: 31533940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of ovarian tumour causes significant loss of muscle and adipose tissue: a novel mouse model for cancer cachexia study.
    Luan Y; Zhang Y; Yu SY; You M; Xu PC; Chung S; Kurita T; Zhu J; Kim SY
    J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1289-1301. PubMed ID: 35044098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling Human Cancer-induced Cachexia.
    Talbert EE; Cuitiño MC; Ladner KJ; Rajasekerea PV; Siebert M; Shakya R; Leone GW; Ostrowski MC; Paleo B; Weisleder N; Reiser PJ; Webb A; Timmers CD; Eiferman DS; Evans DC; Dillhoff ME; Schmidt CR; Guttridge DC
    Cell Rep; 2019 Aug; 28(6):1612-1622.e4. PubMed ID: 31390573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms to explain wasting of muscle and fat in cancer cachexia.
    Argilés JM; López-Soriano FJ; Busquets S
    Curr Opin Support Palliat Care; 2007 Dec; 1(4):293-8. PubMed ID: 18685378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lcn2 mediates adipocyte-muscle-tumor communication and hypothermia in pancreatic cancer cachexia.
    Lemecha M; Chalise JP; Takamuku Y; Zhang G; Yamakawa T; Larson G; Itakura K
    Mol Metab; 2022 Dec; 66():101612. PubMed ID: 36243318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phases of Metabolic and Soft Tissue Changes in Months Preceding a Diagnosis of Pancreatic Ductal Adenocarcinoma.
    Sah RP; Sharma A; Nagpal S; Patlolla SH; Sharma A; Kandlakunta H; Anani V; Angom RS; Kamboj AK; Ahmed N; Mohapatra S; Vivekanandhan S; Philbrick KA; Weston A; Takahashi N; Kirkland J; Javeed N; Matveyenko A; Levy MJ; Mukhopadhyay D; Chari ST
    Gastroenterology; 2019 May; 156(6):1742-1752. PubMed ID: 30677401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SIRT1-NOX4 signaling axis regulates cancer cachexia.
    Dasgupta A; Shukla SK; Vernucci E; King RJ; Abrego J; Mulder SE; Mullen NJ; Graves G; Buettner K; Thakur R; Murthy D; Attri KS; Wang D; Chaika NV; Pacheco CG; Rai I; Engle DD; Grandgenett PM; Punsoni M; Reames BN; Teoh-Fitzgerald M; Oberley-Deegan R; Yu F; Klute KA; Hollingsworth MA; Zimmerman MC; Mehla K; Sadoshima J; Tuveson DA; Singh PK
    J Exp Med; 2020 Jul; 217(7):. PubMed ID: 32441762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A TGF-β/KLF10 signaling axis regulates atrophy-associated genes to induce muscle wasting in pancreatic cancer.
    Dasgupta A; Gibbard DF; Schmitt RE; Arneson-Wissink PC; Ducharme AM; Bruinsma ES; Hawse JR; Jatoi A; Doles JD
    Proc Natl Acad Sci U S A; 2023 Aug; 120(34):e2215095120. PubMed ID: 37585460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MyD88 signalling is critical in the development of pancreatic cancer cachexia.
    Zhu X; Burfeind KG; Michaelis KA; Braun TP; Olson B; Pelz KR; Morgan TK; Marks DL
    J Cachexia Sarcopenia Muscle; 2019 Apr; 10(2):378-390. PubMed ID: 30666818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNF-α and cancer cachexia: Molecular insights and clinical implications.
    Patel HJ; Patel BM
    Life Sci; 2017 Feb; 170():56-63. PubMed ID: 27919820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exercise as an anti-inflammatory therapy for cancer cachexia: a focus on interleukin-6 regulation.
    Daou HN
    Am J Physiol Regul Integr Comp Physiol; 2020 Feb; 318(2):R296-R310. PubMed ID: 31823669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Energy metabolism in cachexia.
    Rohm M; Zeigerer A; Machado J; Herzig S
    EMBO Rep; 2019 Apr; 20(4):. PubMed ID: 30890538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.